Table 2 Intraprocedural and In-hospital data (Mean ± SD)
From: Early experience with ovation endograft system in abdominal aortic disease
n = 37 | |
|---|---|
Anesthesia | |
Regional | 25 (67.6%) |
Local + conscious sedation | 7 (18.9%) |
General | 5 (13.5%) |
Vascular access | |
Percutaneous femoral | 27 (73%) |
Percutaneous brachial (additional) | 2 (5.4%) |
Surgical femoral | 10 (27%) |
Time of operation (min) | 43.1 ± 3.2 |
Amount of contrast (cc) | 28.3 ± 2.5 |
Fluoroscopy time (min) | 11.3 ± 1.5 |
Blood loss (cc) | 110 ± 16 |
Primary success | 33 (89.2%) |
Adjunctive procedure* | 4 (10.8%) |
Length of stay (days) | 3.6 ± 0.9 |
30-day results | |
Death | 0 (0%) |
Major adverse events | 0 (0%) |
Endoleak | 0 (0%) |
Long-term results | |
Death | 0 (0%) |
Major adverse events | 0 (0%) |
Endoleak type II | 2 (5.4%) |
Asintomatic narrowing of iliac limbs | 1 (2.8%) |